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There is increasing evidence that both local and systemic inflammatory responses play an important role in the progression of a
variety of common solid tumours. The aim of the present study was to examine the relationship between tumour T-lymphocyte
subset infiltration, the systemic inflammatory response and cancer-specific survival in patients with colorectal cancer. In all, 147
patients undergoing potentially curative resection for colorectal cancer were studied. Circulating concentrations of C-reactive protein
were measured prior to surgery. CD4þ and CD8þ T-lymphocyte infiltration of the tumour was assessed using
immunohistochemistry and a point counting technique. When patients were grouped according to the percentage tumour volume
of CD4þ T-lymphocytes, there was no difference in terms of age, sex, tumour site, stage and tumour characteristics. However, there
was an inverse relationship between percentage tumour CD4þ T-lymphocytes and C-reactive protein (Po0.01). On univariate
analysis, both C-reactive protein concentrations (Po0.001) and percentage tumour volume of CD4þ (Po0.05) T-lymphocytes
were associated with cancer-specific survival. The results of the present study show that low tumour CD4þ T-lymphocyte
infiltration is associated with elevated C-reactive protein concentrations and both predict poor cancer-specific survival.
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It has long been recognised that disease progression in cancer
patients is not solely determined by the characteristics of the
tumour but also by the host response. Indeed, there is increasing
evidence that both local and systemic inflammatory responses
play an important role in the progression of a variety of common
solid tumours (O’Byrne and Dalgleish, 2001; Vakkila and Lotze,
2004).
In patients with colorectal cancer, there is good evidence that,
on simple staining of tumour sections, the presence of a
pronounced lymphocytic infiltration within the tumour is
associated with improved survival (Jass et al, 1987; Ropponen
et al, 1997; Nielsen et al, 1999). More recently, the ability to
identify lymphocyte subsets by immunohistochemistry has led to
renewed interest in the relationship between the tumour inflam-
matory infiltrate and outcome. Indeed, increased infiltration of the
tumour by CD8þ (Naito et al, 1998) and CD4þ T-lymphocytes
(Ali et al, 2004) has been shown to be associated with increased
survival in patients with colorectal cancer.
There is also increasing evidence that the presence of a systemic
inflammatory response, as evidenced by elevated circulating
concentrations of C-reactive protein, is associated with early
recurrence and poorer survival in patients undergoing potentially
curative resection for colorectal cancer (McMillan et al, 1995, 2003;
Nielsen et al, 2000).
To date, the inter-relationships between the local and systemic
inflammatory responses and outcome does not appear to have
been examined in patients with colorectal cancer. The aim of the
present study was therefore to examine the relationship between
tumour T-lymphocyte subset infiltration, circulating concentra-
tions of C-reactive protein and cancer-specific survival in patients
who had undergone potentially curative resection for colorectal
cancer.
PATIENTS AND METHODS
Patients
Patients with histologically proven colorectal cancer who, on the
basis of preoperative imaging and the surgeons’ assessment at
operation, were considered to have undergone potentially curative
resection for Dukes’ B and C colorectal cancer between January
1997 and August 2001 in a single surgical unit at Glasgow Royal
Infirmary were included in the study. A blood sample was taken
prior to surgery for the measurement of C-reactive protein. The
tumours were staged using conventional Dukes’ classification
(Dukes and Bussey, 1958). All patients were followed up at a
specialist colorectal cancer clinic.
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sC-reactive protein concentrations were measured by a fluores-
cence polarisation immunoassay and using an Abbott TDXTM
analyser and Abbott reagents (Abbott Laboratories, Abbott Park,
IL, USA). The limit of detection of the assay is a CRP concentra-
tion lower than 5mgl
 1. The coefficient of variation, over the
range of measurement, was less than 5%, as established by routine
quality control procedures. Based on previous work, a C-reactive
protein concentration of greater than 10mgl
 1 was considered to
indicate the presence of a systemic inflammatory response
(O’Gorman et al, 2000).
The study was approved by the local ethics committee.
Immunohistochemistry
Blocks from the primary tumour were fixed in 10% buffered
formalin and embedded in paraffin wax. One representative
block of tumour was selected for each patient. Sections (4mm)
were cut and mounted on slides coated with aminopropyl-
triethoxysilane. Sections were then immunostained using the
peroxidase-based Envision (Dako, Cambridgeshire, UK) techn-
ique as described previously (Bromwich et al, 2003). The
primary antibody for CD4 was mouse monoclonal (Vector,
Peterborough, UK) and that for CD8 was mouse monoclonal
(Dako, Cambridgeshire, UK).
Morphometry
Quantitative analysis of the lymphoid infiltrate was performed
using point counting (Anderson and Dunnill, 1965) with a random
sampling technique. With this method, the volume occupied by
any given component (volume density) is expressed as a
percentage of the total volume of the tissue. A 100-point ocular
grid was used at 400  magnification and 30 fields were counted
per case for CD4þ and CD8þ immunopositive cells. Only fields
within the tumour (including cancer cell nests and surrounding
tissue stroma) were counted. Any normal tissue on the slide was
excluded from the analysis.
This final method was designed on the basis of a pilot study,
which demonstrated that the volume density of CD4þ and CD8þ
of two observers reached a plateau after 25–30 fields. This pilot
study also demonstrated that CD4þ and CD8þ counts were
equivalent to the CD3þ counts (unpublished data). The observers
(Canna and McArdle) were blinded to the clinical outcome of the
patient.
Statistics
Data are presented as median and range. Where appropriate,
comparison of patient groups of patients was carried out using
contingency table analysis (w
2) and the Kruskal–Wallis test for
analysis of variance. For the purpose of analysis, T-lymphocyte
subsets were grouped by tertiles as described previously (Nielsen
et al, 1999). Survival analysis was performed using the Cox
proportional-hazard model. Deaths up to 31st March 2004 have
been included in the analysis. Analysis was performed using SPSS
software (SPSS Inc., Chicago, IL, USA).
RESULTS
The baseline clinicopathological characteristics of the patients
(n¼147) who underwent potentially curative resection for colo-
rectal cancer are shown in Table 1. The majority were over the age
of 65years and had Dukes’ stage B tumours. In all, 53 (36%)
patients had an elevated C-reactive protein concentration prior to
surgery.
Patients grouped according to tertiles of the percentage tumour
volume of CD4þ T-lymphocytes are shown in Table 2. The tertiles
Table 1 Clinicopathological characteristics in patients undergoing
potentially curative resection for colorectal cancer
Patients (n¼147)
Age group (years) (o65/65–74/X75) 46/44/57
Sex (male/female) 78/69
Site (colon/rectum) 105/42
Dukes’ stage (B/C) 91/56
C-reactive protein (p10/410mgl
 1) 94/53
Tumour characteristics
Diameter (mm) 40 (10–130)
Ulceration (no/yes) 72/75
Differentiation (well/moderate/poor) 18/116/13
Lymphatic invasion (negative/positive) 124/22
Venous invasion (negative/positive) 118/28
% Tumour volume
CD4+ T-lymphocytes 0.90 (0.03–3.57)
CD8+ T-lymphocytes 1.13 (0.23–6.30)
CD4+ plus CD8+ T-lymphocytes 2.17 (0.50–8.27)
Adjuvant therapy (no/yes) 116/31
Alive/dead 92/55
Cancer-specific/intercurrent disease 39/16
Table 2 Relationship between increasing percentage volume of CD4+ T-lymphocytes and tumour characteristics in patients undergoing potentially
curative resection for colorectal cancer
Percentage volume of CD4+ T-lymphocytes
Tertile (n¼49) Tertile (n¼49) Tertile (n¼49) P-value
Age group (years) (o65/65–74/X75) 12/13/24 19/11/19 15/20/14 0.122
Sex (male/female) 22/27 24/25 32/17 0.101
Site (colon/rectum) 35/14 36/13 34/15 0.905
Dukes’ stage (B/C) 30/19 33/16 28/21 0.578
C-reactive protein (p10/410mgl
 1) 22/27 32/17 39/10 0.002
Tumour characteristics
Diameter (tertiles) 15/17/17 16/12/21 18/20/11 0.250
Ulceration (no/yes) 21/28 22/27 29/20 0.212
Differentiation (well/moderate/poor) 6/38/5 7/37/5 5/41/3 0.883
Lymphatic invasion (negative/positive) 40/8 43/6 41/8 0.794
Venous invasion (negative/positive) 38/10 42/7 38/11 0.554
T-lymphocyte infiltration and colorectal cancer
K Canna et al
652
British Journal of Cancer (2005) 92(4), 651–654 & 2005 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
swere similar in terms of age, sex, tumour site, stage and tumour
characteristics. There was an inverse relationship between
percentage tumour CD4þ T-lymphocytes and C-reactive protein
(rs¼ 0.245, P¼0.003, Figure 1). However, there was no relation-
ship between percentage tumour CD8þ T-lymphocytes and C-
reactive protein (rs¼ 0.091, P¼0.273). There was a positive
relationship between percentage tumour CD4þ and CD8þ T-
lymphocytes (rs¼0.440, Po0.001).
The minimum follow-up was 30 months; the median follow-up
of the survivors was 62 months. During the course of the study, 55
patients died, 39 patients of their cancer and 16 of intercurrent
disease. On univariate analysis, increased age (Po0.001), sex
(P¼0.052), Dukes’ stage (Po0.001) and venous invasion
(P¼0.002) were associated with poorer cancer-specific survival.
A decreased percentage tumour volume of CD4þ T-lymphocytes
(P¼0.025, Figure 2) and an elevated C-reactive protein (Po0.001,
Figure 3) were also associated with poorer cancer-specific survival.
However, the relationship between percentage tumour volume of
CD8þ T-lymphocytes and cancer-specific survival failed to reach
statistical significance (P¼0.074).
On multivariate analysis, only age (HR 2.05, 95% CI 1.30–3.23,
P¼0.002), stage (HR 4.39, 95% CI 2.14–9.00, Po0.001) and C-
reactive protein (HR 4.66, 95% CI 2.20–9.89, Po0.001) retained
independent significance.
DISCUSSION
In the present study, a poor tumour CD4þ T-lymphocyte
infiltrate was associated with an elevated circulating C-reactive
protein concentration in patients undergoing potentially curative
resection for colorectal cancer. Furthermore, both CD4þ T-
lymphocytes and C-reactive protein were associated with a poor
outcome. Therefore, the results of the present study indicate that
both local and systemic inflammatory responses are linked and
predict outcome independent of tumour stage.
These results appear to be consistent with previous work by
Naito et al (1998), who showed that tumour CD8þ T-lymphocyte
infiltrate had prognostic value in patients with colorectal cancer.
However, they did not assess the tumour CD4þ T-lymphocyte
infiltrate and used a less extensive sampling method. Furthermore,
they included patients with Dukes’ A tumours who were unlikely to
progress and patients with Dukes’ D tumours who had already
progressed (Naito et al, 1998).
In the present study, tumour T-lymphocyte subset density was
assessed using extensive sampling and a point counting technique.
This approach provided an objective assessment of lymphocytic
infiltration and circumvents the problem of variation in distribu-
tion of lymphocytes within an individual tumour. The present
study was also confined to patients with Dukes’ B and C tumours.
It was of interest that C-reactive protein (a systemic inflamma-
tory response) was superior to tumour T-lymphocytic infiltration
(a local inflammatory response) in predicting cancer specific
survival. One possible explanation is that C-reactive protein can
be measured with greater accuracy and precision than tumour
T-lymphocytic infiltration. Alternatively, the systemic inflamma-
tory response may be more important in determining survival in
these patients.
The relationship between tumour CD4þ T-lymphocytic infil-
tration and cancer-specific survival is the opposite of that
previously reported for both renal and prostate cancer (Bromwich
et al, 2003; McArdle et al, 2004a). The reasons for this are as yet
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Figure 1 Relationship between percentage tumour CD4þ T-lympho-
cyte infiltration and preoperative C-reactive protein in patients undergoing
potentially curative resection for colorectal cancer.
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Figure 2 Relationship between tumour CD4þ T-lymphocyte infiltra-
tion (tertiles decreasing from top to bottom) and cancer-specific survival in
patients undergoing potentially curative resection for colorectal cancer.
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Figure 3 Relationship between preoperative C-reactive protein (p10/
410mgl
 1 from top to bottom) and cancer-specific survival in patients
undergoing potentially curative resection for colorectal cancer.
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sunclear. However, given that tumour lymphocytic infiltration
parallels that of other inflammatory cells (Nielsen et al, 1999; Lin
and Pollard, 2004) and that an elevated C-reactive protein is
associated with poor outcome in all three tumours (Lewenhaupt
et al, 1990; Blay et al, 1992; McMillan et al, 2003), it appears likely
that the source of interleukin-6, the primary stimulus for the
production of C-reactive protein, (Gabay and Kushner, 1999),
differs in different tumours.
It is of interest therefore that McArdle et al (2004b) have
recently reported that the relationship between interleukin-6 and
C-reactive protein was similar in benign prostatic hyperplasia and
prostate cancer, and that there was no relationship between
interleukin-6 and PSA concentrations. This would suggest that, in
prostate cancer at least, interleukin-6 is produced by the
inflammatory cells.
In colorectal cancer, it has been reported that interleukin-6
concentrations increase with tumour stage and correlate with CEA
concentrations. This might therefore suggest that interleukin-6 is
produced by the tumour cells (Kinoshita et al, 1999; Belluco et al,
2000; Miki et al, 2004). If this were to prove to be the case, it would
have important implications for the treatment of the systemic
inflammatory response in patients with different tumours.
In the present study, we attempted to assess interleukin-6 within
the tumour using different methods of antigen retrieval and
staining and the use of negative and positive controls. However, we
were unable to reliably identify regions of IL-6 expression in the
colorectal tumours due to deep background staining, which
precluded accurate scoring of IL-6-positive cells in the tumour tissue.
In summary, the results of the present study show that, in
patients undergoing curative resection for colorectal cancer, low
tumour CD4þ T-lymphocyte infiltration is associated with
elevated C-reactive protein concentrations. Furthermore, both a
low tumour CD4þ T-lymphocyte infiltration and an elevated
C-reactive protein predict poor cancer-specific survival.
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